Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 CAD | 0.00% | -7.89% | -47.76% |
Mar. 26 | Aptose Biosciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 26 | Transcript : Aptose Biosciences Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
Sales 2024 * | - | Sales 2025 * | 1.04M 757K | Capitalization | 27.51M 19.97M |
---|---|---|---|---|---|
Net income 2024 * | -74M -53.72M | Net income 2025 * | -54M -39.2M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 26.4 x |
P/E ratio 2024 * |
-0.25
x | P/E ratio 2025 * |
-0.36
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.29% |
Latest transcript on Aptose Biosciences Inc.
1 week | -7.89% | ||
Current month | -21.88% | ||
1 month | -12.50% | ||
3 months | -41.08% | ||
6 months | -48.53% | ||
Current year | -47.76% |
Managers | Title | Age | Since |
---|---|---|---|
William Rice
CEO | Chief Executive Officer | 65 | 13-10-27 |
C. Payne
DFI | Director of Finance/CFO | 61 | 22-06-26 |
Chief Tech/Sci/R&D Officer | - | 19-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Denis Burger
BRD | Director/Board Member | 80 | 07-09-18 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 22-09-12 |
Mark Vincent
BRD | Director/Board Member | 71 | 07-09-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 1.75 | 0.00% | 10,978 |
24-04-17 | 1.75 | 0.00% | 7,550 |
24-04-16 | 1.75 | -2.78% | 6,462 |
24-04-15 | 1.8 | -5.26% | 17,996 |
24-04-12 | 1.9 | 0.00% | 13,609 |
Delayed Quote Toronto S.E., April 18, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.76% | 19.93M | |
-1.82% | 41.36B | |
+44.25% | 41.3B | |
+2.56% | 39.61B | |
-12.11% | 25.62B | |
+3.09% | 24.09B | |
-24.16% | 18.38B | |
+22.12% | 11.85B | |
-3.74% | 11.82B | |
+7.75% | 11.07B |
- Stock Market
- Equities
- APS Stock